Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 12781
TargetProcathepsin L(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728214(US20250092029, Compound GC-376)
Affinity DataIC50: 0.0500nMAssay Description:Assays contained 25 pM cathepsin L (RD systems: 952-CY-010), 5 uM LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 20 mM KPO4, p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProcathepsin L(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728213(US20250092029, Compound AP-8-001)
Affinity DataIC50: 1.80nMAssay Description:Assays contained 25 pM cathepsin L (RD systems: 952-CY-010), 5 uM LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 20 mM KPO4, p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetReplicase polyprotein 1ab [3235-3246](HCoV-NL63)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728213(US20250092029, Compound AP-8-001)
Affinity DataIC50: 11nMAssay Description:Recombinant Mpro was obtained and Mpro enzymatic assays were performed as previously described (Tietjen et al., 2021). Briefly, 5 μL of 25 nM recombi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetReplicase polyprotein 1ab [3235-3246](HCoV-NL63)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728214(US20250092029, Compound GC-376)
Affinity DataIC50: 18nMAssay Description:Recombinant Mpro was obtained and Mpro enzymatic assays were performed as previously described (Tietjen et al., 2021). Briefly, 5 μL of 25 nM recombi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetCathepsin B(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728213(US20250092029, Compound AP-8-001)
Affinity DataIC50: 24nMAssay Description:Assays contained 0.6 nM cathepsin B (RD systems: 953-CY-010), 25 uM Z-LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 50 mM MES...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetCathepsin B(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728214(US20250092029, Compound GC-376)
Affinity DataIC50: 37nMAssay Description:Assays contained 0.6 nM cathepsin B (RD systems: 953-CY-010), 25 uM Z-LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 50 mM MES...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetReplicase polyprotein 1ab [3235-3246](HCoV-NL63)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728212(US20250092029, Compound AP-8-013)
Affinity DataIC50: 230nMAssay Description:Recombinant Mpro was obtained and Mpro enzymatic assays were performed as previously described (Tietjen et al., 2021). Briefly, 5 μL of 25 nM recombi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetReplicase polyprotein 1ab [3235-3246](HCoV-NL63)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728216(US20250092029, Compound AP-8-012)
Affinity DataIC50: 580nMAssay Description:Recombinant Mpro was obtained and Mpro enzymatic assays were performed as previously described (Tietjen et al., 2021). Briefly, 5 μL of 25 nM recombi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetReplicase polyprotein 1ab [3235-3246](HCoV-NL63)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728215(US20250092029, Compound AP-8-011)
Affinity DataIC50: 620nMAssay Description:Recombinant Mpro was obtained and Mpro enzymatic assays were performed as previously described (Tietjen et al., 2021). Briefly, 5 μL of 25 nM recombi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetCathepsin B(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728216(US20250092029, Compound AP-8-012)
Affinity DataIC50: 1.80E+3nMAssay Description:Assays contained 0.6 nM cathepsin B (RD systems: 953-CY-010), 25 uM Z-LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 50 mM MES...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProthrombin(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728214(US20250092029, Compound GC-376)
Affinity DataIC50: 1.00E+4nMAssay Description:Assays contained 25 pM thrombin (RD systems: 1473-SE-010), 25 uM BOC—PVR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 μL of 50 mM Tri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProthrombin(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728213(US20250092029, Compound AP-8-001)
Affinity DataIC50: 1.00E+4nMAssay Description:Assays contained 25 pM thrombin (RD systems: 1473-SE-010), 25 uM BOC—PVR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 μL of 50 mM Tri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetCathepsin B(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728215(US20250092029, Compound AP-8-011)
Affinity DataIC50: 1.30E+4nMAssay Description:Assays contained 0.6 nM cathepsin B (RD systems: 953-CY-010), 25 uM Z-LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 50 mM MES...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetCathepsin B(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728212(US20250092029, Compound AP-8-013)
Affinity DataIC50: 1.80E+4nMAssay Description:Assays contained 0.6 nM cathepsin B (RD systems: 953-CY-010), 25 uM Z-LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 50 mM MES...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProcathepsin L(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728216(US20250092029, Compound AP-8-012)
Affinity DataIC50: 2.31E+4nMAssay Description:Assays contained 25 pM cathepsin L (RD systems: 952-CY-010), 5 uM LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 20 mM KPO4, p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProcathepsin L(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728212(US20250092029, Compound AP-8-013)
Affinity DataIC50: 3.20E+4nMAssay Description:Assays contained 25 pM cathepsin L (RD systems: 952-CY-010), 5 uM LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 20 mM KPO4, p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProthrombin(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728215(US20250092029, Compound AP-8-011)
Affinity DataIC50: 3.20E+4nMAssay Description:Assays contained 25 pM thrombin (RD systems: 1473-SE-010), 25 uM BOC—PVR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 μL of 50 mM Tri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProcathepsin L(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728215(US20250092029, Compound AP-8-011)
Affinity DataIC50: 3.20E+4nMAssay Description:Assays contained 25 pM cathepsin L (RD systems: 952-CY-010), 5 uM LR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 uL of 20 mM KPO4, p...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProthrombin(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728216(US20250092029, Compound AP-8-012)
Affinity DataIC50: 3.20E+4nMAssay Description:Assays contained 25 pM thrombin (RD systems: 1473-SE-010), 25 uM BOC—PVR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 μL of 50 mM Tri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent

TargetProthrombin(Human)
The Wistar Institute of Anatomy and Biology

US Patent
LigandPNGBDBM728212(US20250092029, Compound AP-8-013)
Affinity DataIC50: 3.20E+4nMAssay Description:Assays contained 25 pM thrombin (RD systems: 1473-SE-010), 25 uM BOC—PVR-AMC, 100 nL of test compound in 100% DMSO, in at total of 10 μL of 50 mM Tri...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
7/25/2025
Entry Details
US Patent